Document is current
Any future updates will be listed below
-
Authors
Nørgaard, Maibritt
Rusan, Maria
Kondrup, Karoline
Sørensen, Ea Marie Givskov
Weiss, Simone
Bjerre, Marianne Trier
Fredsøe, Jacob
Vang, Søren
Jensen, Jørgen Bjerggaard
De Laere, Bram
Grönberg, Henrik
Borre, Michael
Lindberg, Johan
Sørensen, Karina Dalsgaard
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 4 March 2025
First Online: 14 April 2025
Declarations
:
: The study was approved by the National Committee on Health Research Ethics (#1901101) and the Danish Data Protection Agency (#1–16-02–366-15). All patients provided written informed consent for biobanking. The requirement for patient consent for the specific analyses in this study was waived by the National Committee on Health Research Ethics (#1901101).
: Not applicable.
: Employment or Leadership: M. Borre is chairman for the Danish Prostate Cancer Group and a steering committee member for the Danish Comprehensive Cancer Center.Consultant or Advisory Role: J.B. Jensen has participated on data safety monitoring and/or advisory boards for the following: Roche, Photocure ASA, Olympus, AMBU, Cepheid, and Urotech. H. Grönberg has received consulting fees from Janssen and Astra Zeneca. M. Rusan has participated on advisory boards for Pfizer.Stock Ownership: None declared.Honoraria: J.B. Jensen has received lecturing fees from Olympus and Medac. H. Grönberg has received lecturing fees from Bayer and Astella. M. Borre has received lecturing fees from Astellas, Jansen, Bayer, and MSD. M. Rusan has received lecturing fees from Ipsen and Astra Zeneca, and K.D. Sørensen from Sanofi and “Dagens Medicin.”
